Lumina Laboratories INC

Lumina Laboratories INC was paid $3.33M by Medicaid between Jun 2020 and Nov 2022, across 32 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 77% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#42 of 122

Median peer was paid$1.29M

This provider vs. median2.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	328	$19K
2021	38,601	$1.31M
2022	89,579	$2.00M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	77%	48,458	27,237	$2.56M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	16%	38,317	23,090	$531K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	5.4%	36,774	21,462	$181K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	1,917	1,682	$28K
86769		<1%	232	231	$14K
80050	General health panel	<1%	97	91	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	200	184	$2K
80061	Lipid panel	<1%	253	241	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	254	244	$908.28
84439		<1%	218	201	$862.30
82607		<1%	94	93	$446.49
84481		<1%	94	93	$376.36

20 more codes

84550		<1%	197	$366.00
80053	Comprehensive metabolic panel	<1%	137	$353.23
82977		<1%	97	$326.40
84443	Thyroid stimulating hormone (TSH)	<1%	93	$287.30
83001		<1%	44	$277.28
83002		<1%	43	$260.36
85610		<1%	170	$256.76
85730		<1%	149	$158.92
83540		<1%	67	$157.50
83615		<1%	67	$147.00
84153		<1%	12	$147.00
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	136	$121.43
82248		<1%	91	$110.50
84100		<1%	67	$105.00
85652		<1%	118	$76.50
86430		<1%	58	$46.80
84146		<1%	18	$23.06
84436		<1%	12	$12.00
86140		0%	12	$0.00
84403		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDIN, HAMZA (DIRECTOR)